Literature DB >> 7357319

Multiple sclerosis: what can and cannot be done.

S Poser, W Poser.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7357319      PMCID: PMC1600314          DOI: 10.1136/bmj.280.6208.184-c

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  7 in total

1.  Trial of polyunsaturated fatty acids in non-relapsing multiple sclerosis.

Authors:  D Bates; P R Fawcett; D A Shaw; D Weightman
Journal:  Br Med J       Date:  1977-10-08

2.  Double-blind trial of linoleate supplementation of the diet in multiple sclerosis.

Authors:  J H Millar; K J Zilkha; M J Langman; H P Wright; A D Smith; J Belin; R H Thompson
Journal:  Br Med J       Date:  1973-03-31

3.  Simplified red-cell electrophoretic mobility test for multiple sclerosis.

Authors:  G V Seaman; R L Swank; C H Tamblyn; C F Zukoski
Journal:  Lancet       Date:  1979-05-26       Impact factor: 79.321

4.  Erythrocyte electrophoretic mobility test for multiple sclerosis.

Authors:  S A Hawkins; J H Millar
Journal:  Lancet       Date:  1979-01-20       Impact factor: 79.321

5.  Screening of children at risk of multiple sclerosis.

Authors:  J A Forrester; W J Smith
Journal:  Lancet       Date:  1977-08-27       Impact factor: 79.321

6.  Polyunsaturated fatty acids in treatment of acute remitting multiple sclerosis.

Authors:  D Bates; P R Fawcett; D A Shaw; D Weightman
Journal:  Br Med J       Date:  1978-11-18

7.  Linoleic acid in multiple sclerosis: failure to show any therapeutic benefit.

Authors:  D W Paty; H K Cousin; S Read; K Adlakha
Journal:  Acta Neurol Scand       Date:  1978-07       Impact factor: 3.209

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.